| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
38,046 |
33,819 |
$2.23M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
26,512 |
22,432 |
$2.09M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,613 |
2,272 |
$626K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
32,316 |
18,844 |
$470K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
6,413 |
4,760 |
$408K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
10,609 |
9,017 |
$397K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,168 |
5,530 |
$289K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
7,115 |
6,363 |
$271K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,896 |
2,479 |
$218K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,480 |
4,084 |
$153K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
32,653 |
23,971 |
$148K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
3,229 |
3,058 |
$139K |
| 71045 |
Radiologic examination, chest; single view |
11,418 |
9,231 |
$133K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
3,477 |
1,471 |
$119K |
| 59025 |
Fetal non-stress test |
1,270 |
619 |
$92K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
3,378 |
3,015 |
$85K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,464 |
4,946 |
$83K |
| 97602 |
|
2,272 |
993 |
$65K |
| 99233 |
Prolong inpt eval add15 m |
1,380 |
219 |
$64K |
| 99215 |
Prolong outpt/office vis |
1,171 |
902 |
$51K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,593 |
3,070 |
$44K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,917 |
1,188 |
$40K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,056 |
1,719 |
$37K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
823 |
755 |
$31K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
441 |
319 |
$29K |
| 76830 |
Ultrasound, transvaginal |
697 |
633 |
$26K |
| 71046 |
Radiologic examination, chest; 2 views |
2,335 |
2,079 |
$25K |
| 97597 |
|
1,441 |
510 |
$24K |
| 80053 |
Comprehensive metabolic panel |
45,388 |
34,171 |
$19K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
686 |
174 |
$19K |
| 76642 |
|
611 |
501 |
$19K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,809 |
1,231 |
$18K |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
1,556 |
1,469 |
$18K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
2,645 |
2,371 |
$17K |
| 93798 |
|
612 |
97 |
$14K |
| 0011A |
|
519 |
450 |
$11K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
1,087 |
901 |
$11K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
1,131 |
1,033 |
$11K |
| 77066 |
Tomosynthesis, mammo |
267 |
222 |
$10K |
| 86900 |
|
180 |
161 |
$9K |
| 29581 |
|
128 |
42 |
$9K |
| 0012A |
|
389 |
336 |
$9K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,876 |
2,337 |
$8K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
18,324 |
14,722 |
$7K |
| 36415 |
Collection of venous blood by venipuncture |
31,706 |
22,779 |
$7K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
48,117 |
35,425 |
$6K |
| 71271 |
|
121 |
108 |
$5K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
16 |
13 |
$5K |
| J0185 |
Injection, aprepitant, 1 mg |
157 |
75 |
$4K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,000 |
835 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
78 |
69 |
$4K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,135 |
1,009 |
$4K |
| 93298 |
|
193 |
142 |
$4K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
180 |
154 |
$3K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
128 |
114 |
$3K |
| 86780 |
|
538 |
446 |
$3K |
| 80061 |
Lipid panel |
457 |
428 |
$3K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
101 |
85 |
$3K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
69 |
58 |
$3K |
| 83970 |
|
789 |
638 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,283 |
1,868 |
$2K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
52 |
50 |
$2K |
| 77065 |
Tomosynthesis, mammo |
75 |
54 |
$2K |
| 96415 |
|
69 |
38 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
54 |
50 |
$2K |
| 93248 |
|
96 |
89 |
$2K |
| 97802 |
|
13 |
13 |
$1K |
| 93296 |
|
516 |
412 |
$1K |
| 87070 |
|
251 |
244 |
$1K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
32 |
29 |
$1K |
| 84481 |
|
700 |
626 |
$1K |
| 99223 |
Prolong inpt eval add15 m |
16 |
12 |
$1K |
| 96367 |
|
126 |
64 |
$1K |
| 84425 |
|
110 |
104 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
211 |
198 |
$1K |
| 83735 |
|
4,897 |
2,984 |
$1K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
16 |
15 |
$965.41 |
| 83615 |
|
7,619 |
4,769 |
$947.31 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
325 |
300 |
$917.24 |
| 93016 |
|
81 |
69 |
$909.41 |
| 82728 |
|
429 |
356 |
$901.05 |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
84 |
77 |
$878.51 |
| 93295 |
|
92 |
64 |
$795.83 |
| 93294 |
|
125 |
93 |
$751.73 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,804 |
1,486 |
$729.25 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
30 |
27 |
$699.02 |
| 99460 |
|
16 |
12 |
$696.96 |
| 84480 |
|
79 |
75 |
$644.89 |
| 87631 |
|
306 |
277 |
$621.89 |
| 93018 |
|
81 |
69 |
$606.41 |
| 86762 |
|
63 |
58 |
$576.33 |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
14 |
12 |
$572.48 |
| 93308 |
|
13 |
12 |
$540.11 |
| A9270 |
Non-covered item or service |
3,612 |
1,585 |
$512.49 |
| 93971 |
|
27 |
24 |
$470.85 |
| 84100 |
|
1,480 |
795 |
$441.19 |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
192 |
89 |
$430.38 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
91 |
73 |
$399.68 |
| 86803 |
|
88 |
66 |
$399.63 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
50 |
46 |
$396.03 |
| 87340 |
|
149 |
117 |
$391.11 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
104 |
100 |
$381.75 |
| 76536 |
|
16 |
16 |
$346.70 |
| 81001 |
|
15,136 |
12,958 |
$346.16 |
| 82570 |
|
703 |
575 |
$325.72 |
| 80177 |
|
101 |
80 |
$321.41 |
| 81025 |
|
2,960 |
2,773 |
$309.33 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
84 |
72 |
$299.27 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
14 |
12 |
$283.99 |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
14 |
14 |
$283.00 |
| 82607 |
|
104 |
99 |
$268.68 |
| 86481 |
|
15 |
13 |
$249.20 |
| 87428 |
|
49 |
46 |
$248.85 |
| 84156 |
|
714 |
581 |
$231.07 |
| 84403 |
|
12 |
12 |
$197.23 |
| 84402 |
|
12 |
12 |
$194.62 |
| 73030 |
|
20 |
15 |
$193.02 |
| 84443 |
Thyroid stimulating hormone (TSH) |
366 |
307 |
$191.95 |
| 83880 |
|
1,741 |
1,349 |
$146.76 |
| 83655 |
|
14 |
13 |
$123.54 |
| 82378 |
|
231 |
187 |
$109.37 |
| 86706 |
|
32 |
30 |
$105.44 |
| 84484 |
|
9,001 |
6,688 |
$94.13 |
| 86850 |
|
182 |
163 |
$85.93 |
| 73562 |
|
14 |
12 |
$80.51 |
| 82533 |
|
44 |
26 |
$79.20 |
| 83690 |
|
4,444 |
3,793 |
$67.58 |
| 99152 |
|
19 |
13 |
$46.78 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
21 |
20 |
$44.03 |
| 84439 |
|
38 |
26 |
$43.86 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
238 |
201 |
$41.44 |
| 85027 |
|
102 |
80 |
$39.05 |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
77 |
60 |
$37.56 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,281 |
3,391 |
$36.63 |
| 86901 |
|
180 |
161 |
$29.26 |
| 86300 |
|
240 |
175 |
$17.12 |
| 87430 |
|
12 |
12 |
$16.81 |
| 83605 |
|
929 |
731 |
$9.76 |
| 86704 |
|
16 |
15 |
$8.44 |
| 85007 |
|
21 |
14 |
$5.92 |
| 81003 |
|
2,352 |
2,087 |
$1.58 |
| 85610 |
|
723 |
572 |
$1.40 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,776 |
2,246 |
$0.75 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
427 |
304 |
$0.69 |
| J1956 |
Injection, levofloxacin, 250 mg |
14 |
12 |
$0.32 |
| 87040 |
|
70 |
37 |
$0.20 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
3,172 |
1,500 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
314 |
188 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
412 |
329 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
57 |
46 |
$0.00 |
| 82077 |
|
152 |
138 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
654 |
222 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
619 |
351 |
$0.00 |
| 85730 |
|
71 |
50 |
$0.00 |
| 87077 |
|
87 |
66 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
76 |
74 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
26 |
24 |
$0.00 |
| 87088 |
|
13 |
12 |
$0.00 |
| 80050 |
General health panel |
32 |
31 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
14 |
13 |
$0.00 |
| 96376 |
|
12 |
12 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
37 |
25 |
$0.00 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
29 |
12 |
$0.00 |
| 36591 |
|
47 |
26 |
$0.00 |
| 99024 |
|
14 |
14 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
14 |
14 |
$0.00 |
| 86695 |
|
16 |
13 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
16 |
15 |
$0.00 |
| 86708 |
|
16 |
15 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,943 |
3,262 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,521 |
2,143 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
354 |
252 |
$0.00 |
| 90715 |
|
13 |
12 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
464 |
222 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
366 |
316 |
$0.00 |
| J1756 |
Injection, iron sucrose, 1 mg |
59 |
34 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
154 |
76 |
$0.00 |
| 84702 |
|
16 |
16 |
$0.00 |
| 87186 |
|
14 |
13 |
$0.00 |
| 86696 |
|
16 |
13 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
14 |
12 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
47 |
26 |
$0.00 |
| 84145 |
|
15 |
13 |
$0.00 |
| 86709 |
|
16 |
15 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$0.00 |